Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-04

Clinical Trial Update: Pemetrexed (ALIMTA) Plus Cisplatin Followed by Surgery and Radiation Therapy for Mesothelioma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pemetrexed plus cisplatin followed by surgery and radiation for mesothelioma was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alimta (pemetrexed)
  • Platinol (cisplatin)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Mesothelioma, Pleural Mesothelioma | Phase 2 | Status: TERMINATED